Ischemia-reperfusion Injury Clinical Trial
Official title:
Remote Ischemic Postconditioning Increases HIF-1α Plasma Levels and Improves Cardiac Markers After Cardiac Surgery: a Randomised Controlled Study
NCT number | NCT04284592 |
Other study ID # | PI07/0836 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 2012 |
Est. completion date | October 2017 |
Verified date | February 2020 |
Source | INCLIVA |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background. Cardiopulmonary bypass in on-pump cardiac surgery (OPCS) can have harmful effects
by ischemia-reperfusion. No data about the effects of remote ischemic postconditioning (RIP)
in hypoxia-inducible factor-1 alpha (HIF-1α) plasma level after OPCS. The aim of this study
is evaluate the effects of RIP on postoperative HIF-1α plasma levels, cardiac markers and
arterial oxygenation of patients after OPCS.
Methods. Randomised controlled study in 70 patients undergoing OPCS: 35 patients receive RIP
(RIP group) and 35 patients not (control group). Patients receive RIP on upper limb: 5 min of
ischemia followed by 5 min of reperfusion (3 cycles) immediately after leaving on-pump. The
primary outcome was to know the HIF-1α plasma levels after surgery in both groups: before
starting surgery (T0) and after CPB period at 2 h (T1), 8 h (T2), 24 h (T3), 36 h (T4), 48 h
(T5). Secondary outcomes included to measure the cardiac markers levels (Troponin T, CK-MB,
CPK), arterial oxygenation (PaO2/FiO2) and others.
Status | Completed |
Enrollment | 70 |
Est. completion date | October 2017 |
Est. primary completion date | June 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - elective cardiac surgery (coronary arteries and/or valve replacement) - ASA physical status III or less Exclusion Criteria: - pregnancy - previous cardiac surgery - myocardial infarction (< 6 weeks) - renal failure - severe chronic pulmonary disease. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
José García de la Asunción |
Cai Z, Luo W, Zhan H, Semenza GL. Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17462-7. doi: 10.1073/pnas.1317158110. Epub 2013 Oct 7. — View Citation
García-de-la-Asunción J, Pastor E, Perez-Griera J, Belda FJ, Moreno T, García-del-Olmo E, Martí F. Oxidative stress injury after on-pump cardiac surgery: effects of aortic cross clamp time and type of surgery. Redox Rep. 2013;18(5):193-9. doi: 10.1179/1351000213Y.0000000060. — View Citation
Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM; ERICCA Trial Investigators. Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. N Engl J Med. 2015 Oct 8;373(15):1408-17. doi: 10.1056/NEJMoa1413534. Epub 2015 Oct 5. — View Citation
Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016 Apr;13(4):193-209. doi: 10.1038/nrcardio.2016.5. Epub 2016 Feb 4. Review. — View Citation
Heusch G, Bøtker HE, Przyklenk K, Redington A, Yellon D. Remote ischemic conditioning. J Am Coll Cardiol. 2015 Jan 20;65(2):177-95. doi: 10.1016/j.jacc.2014.10.031. Review. — View Citation
Kalakech H, Tamareille S, Pons S, Godin-Ribuot D, Carmeliet P, Furber A, Martin V, Berdeaux A, Ghaleh B, Prunier F. Role of hypoxia inducible factor-1a in remote limb ischemic preconditioning. J Mol Cell Cardiol. 2013 Dec;65:98-104. doi: 10.1016/j.yjmcc.2013.10.001. Epub 2013 Oct 17. — View Citation
Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993 Mar;87(3):893-9. — View Citation
Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5510-4. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Study of time course of HIF-1a plasma levels (absorbance units) after on-pump cardiac surgery | Hipoxia induced factor 1 alpha (HIF-1a) is a transcriptional factor. Arterial blood samples were collected from the radial artery to evaluate the changes in HIF-1a plasma levels induced in patients undergoing on-pump cardiac surgery. Because we think that ischemic post-conditioning (RIP) can increase plasma HIF-1a plasma levels. | Before starting surgery, is the basal time (Time 0) | |
Primary | Study of time course of HIF-1a plasma levels (absorbance units) after on-pump cardiac surgery | Hipoxia induced factor 1 alpha (HIF-1a) is a transcriptional factor. Arterial blood samples were collected from the radial artery to evaluate the changes in HIF-1a plasma levels induced in patients undergoing on-pump cardiac surgery. Because we think that ischemic post-conditioning (RIP) can increase plasma HIF-1a plasma levels. | 2 hours after cardiopulmonary bypass period (Time 1) | |
Primary | Study of time course of HIF-1a plasma levels (absorbance units) after on-pump cardiac surgery | Hipoxia induced factor 1 alpha (HIF-1a) is a transcriptional factor. Arterial blood samples were collected from the radial artery to evaluate the changes in HIF-1a plasma levels induced in patients undergoing on-pump cardiac surgery. Because we think that ischemic post-conditioning (RIP) can increase plasma HIF-1a plasma levels. | 8 hours after cardiopulmonary bypass period (Time 2) | |
Primary | Study of time course of HIF-1a plasma levels (absorbance units) after cardiac surgery | Hipoxia induced factor 1 alpha (HIF-1a) is a transcriptional factor. Arterial blood samples were collected from the radial artery to evaluate the changes in HIF-1a plasma levels induced in patients undergoing on-pump cardiac surgery. Because we think that ischemic post-conditioning (RIP) can increase plasma HIF-1a plasma levels. | 24 hours after cardiopulmonary bypass period (Time 3) | |
Primary | Study of time course of HIF-1a plasma levels (absorbance units) after on-pump cardiac surgery | Hipoxia induced factor 1 alpha (HIF-1a) is a transcriptional factor. Arterial blood samples were collected from the radial artery to evaluate the changes in HIF-1a plasma levels induced in patients undergoing on-pump cardiac surgery. Because we think that ischemic post-conditioning (RIP) can increase plasma HIF-1a plasma levels. | 36 hours after cardiopulmonary bypass period (Time 4) | |
Primary | Study of time course of HIF-1a plasma levels (absorbance units) after on-pump cardiac surgery | Hipoxia induced factor 1 alpha (HIF-1a) is a transcriptional factor. Arterial blood samples were collected from the radial artery to evaluate the changes in HIF-1a plasma levels induced in patients undergoing on-pump cardiac surgery. Because we think that ischemic post-conditioning (RIP) can increase plasma HIF-1a plasma levels. | 48 hours after cardiopulmonary bypass period (Time 5). | |
Secondary | Study of time course of cardiac marker, Troponin T plasma levels (ng/l) | Troponin T (ng/l) plasma levels. Similar to HIF-1a measures were studied in six arterial blood samples, which were collected from a radial artery line at 6 specific time points (Time 0 to Time 5). | In summary, not repetitive (6 time points): after anesthetic induction, before starting surgery (Time 0) and after cardiopulmonary bypass period, at 2 hrs (Time 1), 8 hrs (Time 2), 24 hrs (Time 3), 36 hrs (T4), 48 hrs (Time 5). | |
Secondary | Study of time course of cardiac marker, creatine phospho-kinase (CPK) plasma levels (U/l) | Creatine phospho-kinase (CPK) plasma levels (U/l). Similar to HIF-1a measures were studied in six arterial blood samples, which were collected from a radial artery line at 6 specific time points (Time 0 to Time 5). | In summary, not repetitive (6 time points): after anesthetic induction, before starting surgery (Time 0) and after cardiopulmonary bypass period, at 2 hrs (Time 1), 8 hrs (Time 2), 24 hrs (Time 3), 36 hrs (T4), 48 hrs (Time 5). | |
Secondary | Study of time course of cardiac marker, creatine kinase-MB (CK-MB) plasma levels (ng/ml) | Creatine kinase-MB (CK-MB) plasma levels (ng/ml). Similar to HIF-1a measures were studied in six arterial blood samples, which were collected from a radial artery line at 6 specific time points (Time 0 to Time 5). | In summary, not repetitive (6 time points): after anesthetic induction, before starting surgery (Time 0) and after cardiopulmonary bypass period, at 2 hrs (Time 1), 8 hrs (Time 2), 24 hrs (Time 3), 36 hrs (T4), 48 hrs (Time 5). | |
Secondary | Study of time course of arterial oxygenation marker (PO2/FiO2), after on-pump cardiac surgery | Oxygenation marker (PO2/FiO2). Similar to HIF-1a measures were studied in six arterial blood samples, which were collected from a radial artery line at 6 specific time points (Time 0 to Time 5). | In summary, not repetitive (6 time points): after anesthetic induction, before starting surgery (Time 0) and after cardiopulmonary bypass period, at 2 hrs (Time 1), 8 hrs (Time 2), 24 hrs (Time 3), 36 hrs (T4), 48 hrs (Time 5). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05327348 -
Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery
|
Phase 3 | |
Completed |
NCT00184912 -
The Effect of Caffeine on Ischemic Preconditioning
|
N/A | |
Recruiting |
NCT05585255 -
Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
|
||
Completed |
NCT05598177 -
Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass
|
Phase 4 | |
Withdrawn |
NCT00441714 -
Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise
|
N/A | |
Completed |
NCT00248040 -
Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation
|
Phase 2 | |
Completed |
NCT01486212 -
Ischemia-reperfusion Injury Model on Healthy Volunteers and Measurement of Oxidative and Inflammatory Markers
|
N/A | |
Recruiting |
NCT06097702 -
A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants
|
Phase 1 | |
Completed |
NCT00224406 -
Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation
|
Phase 2 | |
Completed |
NCT01073202 -
Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation
|
N/A | |
Completed |
NCT05246618 -
FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT02118753 -
The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium
|
N/A | |
Completed |
NCT01739088 -
Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery
|
N/A | |
Completed |
NCT01040013 -
Gut Oxygenation and Laparoscopy
|
Phase 2 | |
Suspended |
NCT00184847 -
Adenosine Receptors Influence Ischemia-Reperfusion Injury
|
N/A | |
Completed |
NCT01172171 -
The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction
|
Phase 2 | |
Completed |
NCT00457405 -
Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
|
Phase 4 | |
Completed |
NCT00184821 -
Ischemic Injury and Ischemic Preconditioning in Diabetes
|
N/A | |
Not yet recruiting |
NCT00691613 -
Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model
|
N/A | |
Completed |
NCT03818126 -
The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement
|
N/A |